Sandoz Files for DJ against Novo Nordisk

  • August 18, 2011

Sandoz filed an action for declaratory judgment against Novo Nordisk over a patent related to an NIDDM regimen for the treatment of type 2 diabetes.  8/17, Eastern District of Michigan, 2:2011cv13594.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×